Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.41 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.40 |
| ▸ | HTR6 known ✓ | P50406 | 5/20 | 0.39 |
| ▸ | HRH1 known ✓ | P35367 | 1/20 | 0.38 |
| ▸ | HTR1A known ✓ | P08908 | 1/20 | 0.38 |
| ▸ | HTR1D known ✓ | P28221 | 1/20 | 0.38 |
| ▸ | HTR1B known ✓ | P28222 | 1/20 | 0.38 |
| ▸ | HTR1F known ✓ | P30939 | 1/20 | 0.38 |
| ▸ | HTR7 known ✓ | P34969 | 1/20 | 0.38 |
| ▸ | DRD3 known ✓ | P35462 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 8/20 | 0.50 |
| ▸ | F2 | P00734 | 2/20 | 0.47 |
| ▸ | TMPRSS4 | Q9NRS4 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL739468 | 0.98 | TAAR1 (0.52) | TAAR1F2TMPRSS4TP53CYP1A2 | |
| SCHEMBL30009738 | 0.98 | TAAR1 (0.52) | TAAR1F2TMPRSS4TP53CYP1A2 | |
| SCHEMBL6680949 | 0.82 | TAAR1 (0.50) | TAAR1HTR2ASLC6A2HTR6HRH1 | |
| SCHEMBL5149827 | 0.82 | ELANE (0.44) | TAAR1F2TMPRSS4TP53CYP1A2 | |
| Hydrochloric Acid SCHEMBL14157101 | 0.81 | TAAR1 (0.48) | TAAR1F2TMPRSS4CYP1A2CYP2D6 | |
| SCHEMBL731097 | 0.80 | TAAR1 (0.52) | TAAR1CYP1A2CYP2D6HTR2ASLC6A2 | |
| SCHEMBL1805940 | 0.78 | TAAR1 (0.50) | TAAR1CYP1A2HTR2ASLC6A2HTR6 | |
| SCHEMBL8337031 | 0.78 | TAAR1 (0.50) | TAAR1CYP1A2CYP2D6HTR2ASLC6A2 | |
| SCHEMBL39171 | 0.77 | TAAR1 (0.45) | TAAR1F2HTR2ASLC6A2HTR6 | |
| SCHEMBL4598969 | 0.77 | TAAR1 (0.48) | TAAR1HTR2ASLC6A2HTR6HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4244378-A1 | METHOD FOR DETECTING NUCLEIC ACIDS IN A BIOLOGICAL SAMPLE | Innovative Diagnostics (FR) | 2023-09-20 | — | — | EP | claimed |
| WO-2022101583-A1 | METHOD FOR DETECTING NUCLEIC ACIDS IN A BIOLOGICAL SAMPLE | INNOVATIVE DIAGNOSTICS GENETICS (FR) | 2022-05-19 | — | — | WO | claimed |
| US-8557581-B2 | Soft tissue processing | MUSCULOSKELETAL TRANSPLANT FOUNDATION (US) | 2013-10-15 | — | — | US | claimed |
| US-7972829-B2 | Process for producing transglutaminase | AJINOMOTO CO., INC. (JP) | 2011-07-05 | — | — | US | claimed |
| US-20100304487-A1 | SOFT TISSUE PROCESSING | MUSCULOSKELETAL TRANSPLANT FOUNDATION (US) | 2010-12-02 | — | — | US | claimed |
| US-20100297729-A1 | PROCESS FOR PRODUCING TRANSGLUTAMINASE | AJINOMOTO CO., INC (JP) | 2010-11-25 | — | — | US | claimed |
| US-20100185219-A1 | REINFORCED BIOLOGICAL MESH FOR SURGICAL REINFORCEMENT | Musculosketetal Transplant Foundation (US) | 2010-07-22 | — | — | US | claimed |
| US-7723108-B2 | Thawing frozen donor dermis and decellularizing; inspecting for defects and trimming; sterilizing in a vacuum with a soak of propylene glycol, ethanol, water and peracetic acid; rinsing; cutting; immersing in ethanol; and packaging; the dermis is flexible when removal from package; ready for implanting | MUSCULOSKELETAL TRANSPLANT FOUNDATION (US) | 2010-05-25 | — | — | US | claimed |
| US-20100112543-A1 | PROCESSING SOFT TISSUE, METHODS AND COMPOSITIONS RELATED THERETO | MUSCULOSKELETAL TRANSPLANT FOUNDATION | 2010-05-06 | — | — | US | claimed |
| EP-2142229-A2 | REINFORCED BIOLOGICAL MESH FOR SURGICAL REINFORCEMENT | Musculoskeletal Transplant Foundation (US) | 2010-01-13 | — | — | EP | claimed |
| EP-2114136-A2 | DECELLULARIZATION OF SOFT TISSUE | Ngo, Manh-Dan (US) | 2009-11-11 | — | — | EP | claimed |
| EP-2114135-A2 | PROCESSING SKIN FROM LIVING DONORS | Ngo, Manh-Dan (US) | 2009-11-11 | — | — | EP | claimed |
| WO-2008134541-A2 | REINFORCED BIOLOGICAL MESH FOR SURGICAL REINFORCEMENT | MUSCULOSKELETAL TRANSPLANT FOUNDATION (US) | 2008-11-06 | — | — | WO | claimed |
| WO-2008097884-A2 | PROCESSING SKIN FROM LIVING DONORS | NGO MANH-DAN (US) | 2008-08-14 | — | — | WO | claimed |
| WO-2008097885-A2 | DECELLULARIZATION OF SOFT TISSUE | NGO MANH-DAN (US) | 2008-08-14 | — | — | WO | claimed |
| EP-1858319-A2 | SOFT TISSUE PROCESSING | Musculoskeletal Transplant Foundation (US) | 2007-11-28 | — | — | EP | claimed |
| US-20060275377-A1 | Thawing frozen donor dermis and decellularizing; inspecting for defects and trimming; sterilizing in a vacuum with a soak of propylene glycol, ethanol, water and peracetic acid; rinsing; cutting; immersing in ethanol; and packaging; the dermis is flexible when removal from package; ready for implanting | MUSCULOSKELETAL TRANSPLAN FOUNDATION | 2006-12-07 | — | — | US | claimed |
| WO-2006101885-A2 | SOFT TISSUE PROCESSING | MUSCULOSKELETAL TRANSPLANT FOUNDATION (US) | 2006-09-28 | — | — | WO | claimed |
| US-20030082746-A1 | Process for producing transglutaminase | AJINOMOTO CO. INC (JP) | 2003-05-01 | — | — | US | claimed |
| EP-1219713-A1 | PROCESS FOR PRODUCING TRANSGLUTAMINASE | Ajinomoto Co., Inc. (JP) | 2002-07-03 | — | — | EP | claimed |